Research.Patient.info
X-linked Hypophosphatemia (XLH) research hub
2 indexed studies · 2 currently recruiting
- recruiting
Effective Dosing of Burosumab in XLH
This study looks at how different doses of a medicine called Burosumab (Crysvita) work for children with a rare bone condition called X-linked Hypophosphataemia (XLH). Researchers are reviewing existing patient records from different hospitals to see which doses are most effective.
United Kingdom - not yet recruiting
Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia
This study looks at how X-linked hypophosphatemia (XLH) affects adults. We're observing people already taking burosumab to understand how their phosphate levels change and how this relates to their bone health and overall well-being. It's about learning more, not trying new treatments.
United States · Australia · Canada